Boehringer Ingelheim
Last updated on 2013-11-20T06:39+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| farmacêutica alemã | 40.00% | PT | 29/12/2016 |
| farmacêutica | 20.00% | PT | 24/05/2016 |
| manufacturer | 20.00% | EN | 23/03/2015 |
| german manufacturer | 20.00% | EN | 23/03/2015 |
| Names | Lang | Count |
|---|---|---|
| Boehringer Ingelheim | EN | 61.60% |
| Boehringer Ingelheim | FR | 14.81% |
| Boehringer Ingelheim Pharmaceuticals | EN | 3.55% |
| Boehringer Ingelheim | PT | 3.10% |
| Boehringer Ingelheim | ES | 2.34% |
| Boehringer Ingelheim | PL | 2.19% |
| Boehringer Ingelheim | DE | 2.19% |
| Boehringer Ingelheim | IT | 2.12% |
| Boehringer Ingelheim | EU | 2.04% |
| Boehringer Ingelheim | SV | 2.04% |
| Boehringer-Ingelheim | EN | 1.74% |
| Boehringer-Ingelheim | FR | 1.51% |
| Boehringer-Ingelheim Pharmaceuticals | EN | 0.23% |
| Boehringer Ingelheim | AR | 0.15% |
| BOEHRINGER INGELHEIM | EN | 0.08% |
| Boehringer-Ingelheim Pharmaceuticals | FR | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | PT | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | ES | 0.08% |
| Boehringer-Ingelheim | DE | 0.08% |
| ベーリンガーインゲルハイム | JA | 0.00% |
| 勃林格殷格翰 | ZH | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 6.74% |
| Novartis | 4.21% |
| Eli Lilly | 3.48% |
| Pfizer Inc | 3.37% |
| Novo Nordisk | 2.95% |
| Bristol Myers Squibb | 2.74% |
| GlaxoSmithKline | 2.21% |
| Pharmaceuticals Inc | 2.11% |
| World Health Organization | 2.00% |
 | Solutions | 1.26% |
| Drug Administration | 1.26% |
| Commission | 1.16% |
| Association | 1.05% |
| Teva Pharmaceuticals | 1.05% |
| Product Development | 1.05% |
| Daiichi Sankyo | 0.95% |
| Laura Wood | 0.95% |
| Astellas Pharma | 0.95% |
| Kyowa Hakko Kirin | 0.84% |
| Kyowa Hakko | 0.84% |
| European Union | 0.84% |
| Roche Holding AG | 0.84% |
| Frankfurt Stock Exchange | 0.74% |
| Takeda Pharmaceutical | 0.74% |
| Cancer Research | 0.74% |
| GlaxoSmithKline Plc | 0.74% |
| Clinical Development | 0.74% |
| Eisai Co | 0.63% |
| Medicines Agency | 0.63% |
| Dr Reddy | 0.63% |
| Type | Entity Name | Score |
|---|---|---|
| Kenneth Moch | 0.0588 |
| Novartis | 0.0384 |
| Eli Lilly | 0.0312 |
| Cord Dohrmann | 0.0299 |
| Novo Nordisk | 0.0272 |
| Bristol Myers Squibb | 0.0259 |
| Ambarish Pandey | 0.0227 |
| Pharmaceuticals Inc | 0.0188 |
| Pfizer Inc | 0.015 |
| GlaxoSmithKline | 0.0147 |
| Craig Johnstone | 0.0116 |
| Victor Velculescu | 0.0112 |
| Inc | 0.0106 |
| Human Genome Sciences Inc | 0.0103 |
| Drug Administration | 0.0099 |
| Teva Pharmaceuticals | 0.0099 |
| Product Development | 0.0098 |
| Carlo Erba | 0.0093 |
| Alexis Peyroles | 0.0092 |
| Daiichi Sankyo | 0.0091 |
| Laura Wood | 0.0084 |
| Astellas Pharma | 0.0083 |
| Kyowa Hakko | 0.0082 |
| Kyowa Hakko Kirin | 0.008 |
| Roche Holding AG | 0.0079 |
| Sir John Gurdon | 0.0079 |
| Takeda Pharmaceutical | 0.0076 |
| Advanced Cell Technology | 0.0074 |
| Wilbur-Ellis | 0.0074 |
| Frankfurt Stock Exchange | 0.0069 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Tuesday, January 28, 2020
8:47:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 